Robust hepatitis E virus infection and transcriptional response in human hepatocytes.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Meister, Toni Luise
Pfankuche, Vanessa M
Vondran, Florian W R
MetadataShow full item record
AbstractHepatitis E virus (HEV) is the causative agent of hepatitis E in humans and the leading cause for acute viral hepatitis worldwide. The virus is classified as a member of the genus Orthohepevirus A within the Hepeviridae family. Due to the absence of a robust cell culture model for HEV infection, the analysis of the viral life cycle, the development of effective antivirals and a vaccine is severely limited. In this study, we established a protocol based on the HEV genotype 3 p6 (Kernow C-1) and the human hepatoma cell lines HepG2 and HepG2/C3A with different media conditions to produce intracellular HEV cell culture-derived particles (HEVcc) with viral titers between 105 and 106 FFU/mL. Viral titers could be further enhanced by an HEV variant harboring a mutation in the RNA-dependent RNA polymerase. These HEVcc particles were characterized in density gradients and allowed the trans-complementation of subgenomic reporter HEV replicons. In addition, in vitro produced intracellular-derived particles were infectious in liver-humanized mice with high RNA copy numbers detectable in serum and feces. Efficient infection of primary human and swine hepatocytes using the developed protocol could be observed and was inhibited by ribavirin. Finally, RNA sequencing studies of HEV-infected primary human hepatocytes demonstrated a temporally structured transcriptional defense response. In conclusion, this robust cell culture model of HEV infection provides a powerful tool for studying viral-host interactions that should facilitate the discovery of antiviral drugs for this important zoonotic pathogen.
CitationProc Natl Acad Sci U S A. 2020 Jan 2. pii: 1912307117. doi: 10.1073/pnas.1912307117.
AffiliationTWINCORE, Zentrum für experimentelle und klinische Infektionsforschung GmbH,Feodor-Lynen Str. 7, 30625 Hannover, Germany.
PublisherNational Academy of Sciences
The following license files are associated with this item:
- Creative Commons
- Zinc Salts Block Hepatitis E Virus Replication by Inhibiting the Activity of Viral RNA-Dependent RNA Polymerase.
- Authors: Kaushik N, Subramani C, Anang S, Muthumohan R, Shalimar, Nayak B, Ranjith-Kumar CT, Surjit M
- Issue date: 2017 Nov 1
- A rat model for hepatitis E virus.
- Authors: Debing Y, Mishra N, Verbeken E, Ramaekers K, Dallmeier K, Neyts J
- Issue date: 2016 Oct 1
- Vectorial Release of Hepatitis E Virus in Polarized Human Hepatocytes.
- Authors: Capelli N, Marion O, Dubois M, Allart S, Bertrand-Michel J, Lhomme S, Abravanel F, Izopet J, Chapuy-Regaud S
- Issue date: 2019 Feb 15
- The natural compound silvestrol inhibits hepatitis E virus (HEV) replication in vitro and in vivo.
- Authors: Todt D, Moeller N, Praditya D, Kinast V, Friesland M, Engelmann M, Verhoye L, Sayed IM, Behrendt P, Dao Thi VL, Meuleman P, Steinmann E
- Issue date: 2018 Sep
- Positive Regulation of Hepatitis E Virus Replication by MicroRNA-122.
- Authors: Haldipur B, Bhukya PL, Arankalle V, Lole K
- Issue date: 2018 Jun 1